Fermenta Biotech Ltd

As of 17-Nov, Fermenta Biotech Ltd's stock is priced at 276.80, down 5.16% and underperforming with a year-to-date decline of 23.95%. Investor confidence is low, as indicated by a 62.9% drop in delivery volume compared to the five-day average.

As of November 13, 2025, Fermenta Biotec's trend is mildly bearish due to bearish weekly MACD and KST indicators, despite a bullish outlook from monthly Bollinger Bands, indicating a cautious approach is advisable.

As of 13-Nov, Fermenta Biotech Ltd's stock price is at 291.15, having increased by 2.03% today and showing strong short-term performance with a 5.37% rise over the past week. However, it remains down 20.00% year-to-date and has underperformed against the benchmark in the longer term.

Fermenta Biotec has shown a recovery in financial performance, with net sales increasing from 335.66 Cr in Mar'24 to 469.48 Cr in Mar'25, leading to a profit after tax of 76.40 Cr, a turnaround from a loss the previous year. However, total expenditure also rose, and cash flow from operating activities decreased.

Fermenta Biotech's latest Q2 FY26 results show a year-on-year sales growth of 37.03% and a net profit increase of 65.91%, indicating recovery; however, there are sequential declines in both sales and profits, raising concerns about the sustainability of this recovery. Overall, while the company has improved from past losses, ongoing operational challenges warrant careful monitoring.

As of 28 October 2025, Fermenta Biotec's technical trend is bearish with moderate strength, indicated by bearish signals from the weekly MACD, KST, Bollinger Bands, and daily moving averages, while the monthly indicators show mild bearishness and the RSI indicates market indecision.

As of 15-Oct, Fermenta Biotech Ltd's stock price is at 276.60, showing a recent increase after two days of decline, but it has underperformed in the short term with significant losses over the past month. Despite a rise in investor interest indicated by increased delivery volume, the stock remains below its moving averages and has lagged behind the benchmark Sensex.

As of 13-Oct, Fermenta Biotech Ltd's stock price is at 296.80, down 1.18%, and has underperformed its sector. The stock is in a downward trend, trading below all key moving averages, with significant declines over the past week, month, and year, contrasting with the broader market's positive performance.

As of October 8, 2025, Fermenta Biotec's technical trend is mildly bearish, supported by bearish MACD readings, Bollinger Bands signals, and underperformance against the Sensex, despite some mildly bullish daily moving averages.

As of October 6, 2025, Fermenta Biotec's technical trend is neutral with mixed signals, showing weak bullishness on daily moving averages but mildly bearish indicators on weekly and monthly charts.

Fermenta Biotec experienced significant financial recovery in the latest fiscal year, with net sales rising to 469.48 Cr and profit after tax improving to 76.40 Cr, compared to losses in the previous year. Operating profit margin increased to 23.39%, indicating a positive turnaround in performance.

As of October 1, 2025, Fermenta Biotec is considered very attractive for investment due to its undervalued status, highlighted by a PE ratio of 9.21 and strong growth potential, despite a recent decline in stock performance compared to the Sensex.